COMPOUND WITH CONFIDENCE: PCCA Membership, $895/month.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

202311_Blog_EctoSeal-Image.jpg

EctoSeal P2G, our revolutionary powder-to-hydrogel base, is the first natural, biodegradable polymer base created for wound care preparations. Read about the motivation behind its development, as well as clinical applications, from PCCA Clinical Compounding Pharmacist Mark Gonzalez, PharmD.

202311_BB_New CS people_1768x923.jpg

We are excited to introduce three members of our Clinical Services team: Matt Lester, RPh, MBA, Catherine Henderson, PharmD, and Celeste Zizzamia, PharmD, BCSCP. Each brings their unique expertise — including addressing business concerns, compounding for lifestyle medicine, as well as compounding for oncology patients and USP 800 minimum standards — to assist our members with questions and concerns. You will also see their respective byline in future PCCA Blog posts and Apothagram articles, as well as featured guests in future Mortar & Pestle podcasts.

202311_BB_ISTX23 Wrapup_823x46252.png

ThinkNext: International Seminar 2023 (ThinkNext: ISTX23) was a huge success, attended by more than 400 global participants. We’re reviewing the pearls — highlights of key takeaways — from the event to rekindle memories and, for those who missed attending, inspire your participation next year.

202310_Blog_Cleanroom2-Repost_1768x923.jpg

Due to pending USP updates that are effective on November 1, 2023, we’re reposting our January Blog, which reviews how a modular compounding cleanroom can meet evolving regulatory requirements and standards.

202309_BB_Hypogonadism-Men's Health_823x462.png

Read how estrogen levels in men impact testosterone levels, the consequences of low testosterone and the potential ways compounding pharmacies can help.

202309_BB_Covid-Vertigo_823x462.png

Multiple studies indicate some patients with COVID-19 infection may develop vertigo. Read how betahistine helped relieve symptoms of vertigo in these post-COVID patients.

202309_BB_Oxytocin_823x462-B6.png

Review the criteria for selecting an FDA-approved API to safeguard your patients and your compounding pharmacy.

202308_BB_USP Chapter 797_823x462.png

Read what we’re doing to ensure PCCA Formulas for compounding sterile preparations comply with USP Chapter 797 revisions.

202308_BB_Methylene Blue_823x462.png

From its humble origins as a textile dye, methylene blue has transformed into a versatile clinical agent with a wide range of potential applications.

202308_BB_Flavoring Challenges_823x462.png

Get flavoring tips for masking two bitter active pharmaceutical ingredients (APIs) from our flavoring expert.